DOCSLIB.ORG

TCU – HARRIS COLLEGE of NURSING & HEALTH SCIENCES CURRICULUM VITA Dennis J

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
TCU – HARRIS COLLEGE of NURSING & HEALTH SCIENCES CURRICULUM VITA Dennis J TCU – HARRIS COLLEGE OF NURSING & HEALTH SCIENCES CURRICULUM VITA Dennis J. Cheek, RN, PhD, FAHA 1. Educational Background Ph.D. (Cellular Molecular). (1996). University of Nevada School of Medicine, Reno, NV. M.S.N (Clinical Nurse Nursing Specialist). (1988). University of California School of Nursing, San Francisco, CA. B.S.N. (1982). California State University, Fresno, CA. A.S. (Biological Science/Pre-nursing). (1979). Yuba College, Marysville, CA. 2. Formal Continuing Education Associated with Professional Development American Heart Association. (July 1996-June 1997). Post-Doctoral-Nevada Affiliate, Inc. Fellowship. 3. Present Rank Abell-Hanger Professor of Gerontological Nursing 4. Presentation of Scholarly and Creative Activities a. Refereed publications, invitational or juried shows, critically evaluated performances, scholarly monographs Cheek, D.J. and Howington, L. (2018). Pharmacogenomics in critical care. AACN Advances in Critical Care. 29:36-42; doi:10.4037/aacnacc2018398 Cheek, D.J. and Howington, L.H. (2017). Patient care in the dawn of the genomic age. New scientific developments come with new nursing considerations. American Nurse Today,12(3), 16-22. (CE) Cheek, D.J. (2017). Pharmacogenomics: Strategies for individualized care. Nursing CriticalCare2017, 12(1), 22-31. Cheek, D.J. & Bashore, L., Brazeau, D. (2015). Pharmacogenomics and implications for nursing practice. Journal of Nursing Scholarship, 47(6):496-504. Article first published online: 15 OCT 2015 DOI: 10.1111/jnu.12168 Cheek, D. & Brazeau, D. (2015). Genetically modified. Nursing Management-UK, 22(3):13. Cheek, D.J. (2013). Mutation and Von Willebrand disease. Nursing2013CriticalCare, 8(3):11-13. Cheek, D.J. (2013). What you need to know about pharmacogenomics. Nursing2013-1/30/2013 ePub ahead of print. Nursing2013, 43(3), 44-48. Howington, L., Riddlesperger, K., & Cheek, D.J. (2011). Essential nursing competencies for genetics and genomics: Implications for critical care. Critical Care Nurse, 31(5),e1-e7. doi: 10.4037/ccn2011867. Anderson-Pompa, K., Foster, A., Parker, L., Wilks, L., & Cheek, D. J. (2008). Genetics and susceptibility to malignant hyperthermia. Critical Care Nurse, 28(6), 32-37. Cheek, D. J., & Cesan, A. (2003). Genetic predictors of cardiovascular disease: The use of chip technology. The Journal of Cardiovascular Nursing, 18(1), 50-56. Cheek, D. J. (2002). Preface: Current issues in genetics. AACN Clinical Issues: Advanced Practice in Acute and Clinical Care, 13(4), 485. Tinkle, M., & Cheek, D. J. (2002). Human genomic: Challenges and opportunities. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 31(2), 30-38. *Buxton, I. L. O., Kaiser, R. A., Oxhorn, B. C., & Cheek, D. J. (2001). Evidence supporting the nucleotide axis hypothesis: ATP release and metabolism by coronary endothelium. American Journal of Physiology: Heart and Circulatory, 281, 1657-1666. Cheek, D. J. (2001). Genomics and nursing. Central Lines, 17(3), 14. *Moser, T. L., Kenan, D. J., Uma, K., Ashley, T. A., Roy, J. A., Goodman, M. D., Cheek, D. J., & Pizzo, S. V. (2001). Endothelial cell surface F1 FO ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proceedings of the National Academy of Sciences, 98(12), 6656-61. *Yang, S., Cheek, D. J., Westfall, D. P., & Buxton, I. L. O. (1994). A purinergic axis in cardiac blood vessels: Agonist mediated release of ATP from cardiac endothelial cells. Circulation Research, 74(3), 401-407. *Buxton, I. L. O., Cheek, D. J., Eckman, D. M., Westfall, D. P., Sanders, K. M., & Keef, K. D. (1993). Nitro-1-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonist. Circulation Research, 72(2), 387-395. b.Non-refereed publications (include publications arising from presentations, i.e., proceedings), exhibits, performances, textbooks, chapter) Textbook-Chapters Cheek, D. J. (2015). Pharmacogenomics and older adult patients. In D.H. Lea, D.Cheek, D. Brazeau & G. Brazeau (Eds.), Mastering Pharmacogenomics: A nurse’s handbook for success. Indianaolis, IN, Sigma Theta Tau International. Cheek, D.J. (2013). Spotlight on Genetics. In P.G. Morton & D.K. Fontaine (Eds.), Critical Care Nursing : A Holistic Approach (10th edition). Philadelphia, PA Lippincott Williams & Wilkins. Edkins, R. E., & Cheek, D. J. (2006). Pharmacogenetics. In M. Runge & C. Patterson (Eds.), Principles of molecular medicine (pp. 34-38). Totowa, NJ: Humana Press. Journal articles Cheek, D.J. (2015). Why nurses need to be informed about pharmacogenomics. Reflections on Nursing Leadership-STTI. Cheek, D.J. & Brazeau, D. (2015). It’s all in the genes/Interviewer Elly Earls. Pharma Technology Focus Magazine, 35, 1-4. c. Papers presented, participation on panels, etc., at scholarly meetings (include date, place, and sponsor of meeting). Include only meetings that involve actual participation on the program. Bashore, L., Borcher, L., Daniels, G., Howington, L & Cheek, D.J. (2016). Integration of Genomics/Genetics into a Nursing Education Curriculum: Ensuring Faculty Competence. STTI 3rd European Regional Conference, Utrecht, The Netherlands. Cheek, D. J. (2012, March 29). Pharmacology, genetics and the older adult. 7th Annual Hogstel Gerontological Nursing Symposium, Fort Worth, Texas. Cheek, D. J. (2002). Human genomics in clinical practice. Presentation at the 10th Annual Acute Care Nurse Practitioner Conference, Charlottesville, VA. Cheek, D. J. (2001). Human genomics in clinical practice. Presentation at the 9th Annual Acute Care Nurse Practitioner Conference, Huntsville, AL. Oral/Podium Presentations Cheek, D.J. (2014, June 26). Pharacogenomics and the older adult. Invited, Keynote Speaker at Cedar- Sinai Medical Center, Geri and Richard Brawerman Nursing Institute-Nursing Research Conference, Los Angeles, California. Cheek, D.J. (2013, May). Pharmacogenomics and clinical practice. Invited to present at AACN-NTI, Boston, Massachusetts. Cheek, D.J. (2013, March). Pharmacogenomics in Clinical Practice (invited speaker). Nursing2013 Symposium-Advanced Track (70 attendees), Las Vegas, Nevada. Cheek, D.J. (2012, September). Pharmacogenomics and clinical practice. Texas Nurse Practitioner Conference, Austin, Texas. Cheek, D. J. (2009). Pharmacogenomics: The genomic connection. Presentation at the 35th National Teaching Institute and Critical Care Exposition of the AACN. 5. Community Activities Directly Related to Professional Skills International Society of Nursing in Genetics (ISONG)-Elected Board Member, 2014-2016 International Society of Nursing in Genetics (ISONG)-Research Committee, Member, 2014-2016 International Society of Nursing in Genetics (ISONG)-Abstract Review, Member, 2012-2014 International Society of Nursing in Genetics (ISONG)-Plenary Committee, 2009-2010 International Society of Nursing in Genetics (ISONG)-Member, 2009-Present 6. Professionally Related Honors and Awards: Recipient of the International Society of Nurses in Genetics (ISONG) Founder Award in Excellence for Genetics Education, 2015 CURRICULUM VITA Allison Amend Vorderstrasse EDUCATION 2011 Certificate NIH/NINR Summer Genetics Institute 2002-2006 DNSc Yale University School of Nursing (Chronic Illness Self-Management) 1999-2002 MSN Yale University School of Nursing (Adult Nurse Practitioner-Diabetes Specialty Concentration) 1996 BSN Mount Saint Mary College CERTIFICATION AACN Adult Nurse Practitioner #0372038 Expires July 31, 2022 PROFESSIONAL EXPERIENCE Academic Professional Experience Associate Professor, with tenure, New York University Rory Myers College of Nursing, and Director of the Florence S. Downs PhD Program in Nursing Research and Theory Development, 2017- Associate Professor (tenure track), Duke University School of Medicine (secondary appointment), 2015-2017 Associate Professor, with tenure, Duke University School of Nursing, May 1 2017 – Sept 2017 Lead Faculty, Precision Health Research, 2016-2017 Dorothy L. Powell Term Chair of Nursing (2017) Associate Professor (tenure track), Duke University School of Nursing, 2014-2017 Assistant Professor (tenure track), Duke University School of Nursing, 2009-2014 Assistant Professor, Marymount University, School of Nursing, 2006-2008 PROFESSIONAL AWARDS AND HONORS Duke University School of Nursing Distinguished Teaching Award 2014 Fellow of the American Academy of Nursing, Inducted October 2015 International Society of Nurses in Genetics Founders Award for Excellence in Genomic Nursing Research, 2017 RESEARCH/GRANT AWARDS (selected) Genomic Risk Testing for Type 2 Diabetes in Primary Care. PI Geoffrey Ginsburg, Co-PIs Alex Cho, A. Vorderstrasse, 2009-2012, Duke Endowment. Co-PI Role: Supervise study coordinators in follow-up data collection, and ongoing statistical analysis and dissemination of findings. Integrative Health Coaching and Genetic Risk Testing in Primary Care: A Multidisciplinary Approach to Personalized Medicine targeting CHD Risk, PI Ruth Wolever, Co-PI A. Vorderstrasse, 2011- 2012, Duke Center for Personalized Medicine, $50,000. Co-PI Role: Oversight of risk counseling profile and intervention; shared responsibility for oversight of study coordinators, statistical analysis and dissemination. GENErating Behavior Change: Genetic CHD and T2D Risk Counseling & Health Coaching for Behavior Change in Military Personnel, Multi-PI A. Vorderstrasse, Co-PI Ruth Wolever, 2013-2016, Air Force Medical Services, $1,400,000 Co-PI Role: Corresponding PI for grant; oversight of risk counseling profile and intervention; shared responsibility for oversight of study coordinators,
Load more

Recommended publications
  • Rates and Patterns of Indels in HIV-1 Gp120 Within and Among Hosts
    Western University Scholarship@Western Electronic Thesis and Dissertation Repository 8-19-2020 1:00 PM Rates and patterns of indels in HIV-1 gp120 within and among hosts John Lawrence Palmer, The University of Western Ontario Supervisor: Poon, Art F.Y., The University of Western Ontario A thesis submitted in partial fulfillment of the equirr ements for the Master of Science degree in Pathology and Laboratory Medicine © John Lawrence Palmer 2020 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Molecular Genetics Commons Recommended Citation Palmer, John Lawrence, "Rates and patterns of indels in HIV-1 gp120 within and among hosts" (2020). Electronic Thesis and Dissertation Repository. 7308. https://ir.lib.uwo.ca/etd/7308 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. Abstract Insertions and deletions (indels) in the HIV-1 gp120 variable loops modulate sensitivity to neutralizing antibodies and are therefore implicated in HIV-1 immune escape. However, the rates and characteristics of variable loop indels have not been investigated within hosts. Here, I report a within-host phylogenetic analysis of gp120 variable loop indels, with mentions to my preceding study on these indels among hosts. We processed longitudinally-sampled gp120 sequences collected from a public database (n = 11,265) and the Novitsky Lab (n=2,541). I generated time-scaled within-host phylogenies using BEAST, extracted indels by reconstructing ancestral sequences in Historian, and esti- mated variable loop indel rates by applying a Poisson-based model to indel counts and time data.
    [Show full text]
  • The University of Chicago Integrative Genetic
    THE UNIVERSITY OF CHICAGO INTEGRATIVE GENETIC ANALYSIS OF BEHAVIORAL AND METABOLIC TRAITS IN AN ADVANCED INTERCROSS LINE OF MICE A DISSERTATION SUBMITTED TO THE FACULTY OF THE DIVISION OF THE BIOLOGICAL SCIENCES AND THE PRITZKER SCHOOL OF MEDICINE IN CANDIDACY FOR THE DEGREE OF DOCTOR OF PHILOSOPHY DEPARTMENT OF HUMAN GENETICS BY NATALIA M. GONZALES CHICAGO, ILLINOIS DECEMBER 2017 Copyright c 2017 by Natalia M. Gonzales All Rights Reserved Freely available under a CC-BY 4.0 International license "Man had always assumed that he was more intelligent than dolphins because he had achieved so much - the wheel, New York, wars and so on... In fact there was only one species on the planet more intelligent than dolphins, and they spent a lot of their time in behavioural research laboratories running round inside wheels and conducting frighteningly elegant and subtle experiments on man. The fact that once again man completely misinterpreted this relationship was entirely according to these creatures' plans." Douglas Adams, The Hitchhiker's Guide to the Galaxy, 1979. Table of Contents LIST OF FIGURES . vi LIST OF TABLES . vii ACKNOWLEDGMENTS . viii ABSTRACT . xi 1 INTRODUCTION . 1 1.1 Genetic approaches for studying phenotypic variation . 1 1.2 Major insights from human GWAS and implications for psychiatric traits . 4 1.3 Model organisms can be used to circumvent some limitations of human GWAS 6 1.4 Genetic analysis in advanced intercross lines . 7 1.5 GWAS in structured populations . 9 1.6 Overview . 10 2 MOUSE GWAS OF INTERMEDIATE PHENOTYPES FOR HUMAN PSYCHI- ATRIC AND METABOLIC DISEASE . 12 2.1 Introduction .
    [Show full text]
  • NLN Mouse Monoclonal Antibody [Clone ID: OTI1D6] Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for CF504178 NLN Mouse Monoclonal Antibody [Clone ID: OTI1D6] Product data: Product Type: Primary Antibodies Clone Name: OTI1D6 Applications: FC, IF, IHC, WB Recommended Dilution: WB 1:500~2000, IHC 1:150, IF 1:100, FLOW 1:100 Reactivity: Human, Monkey, Mouse, Rat Host: Mouse Isotype: IgG1 Clonality: Monoclonal Immunogen: Full length human recombinant protein of human NLN(NP_065777) produced in HEK293T cell. Formulation: Lyophilized powder (original buffer 1X PBS, pH 7.3, 8% trehalose) Reconstitution Method: For reconstitution, we recommend adding 100uL distilled water to a final antibody concentration of about 1 mg/mL. To use this carrier-free antibody for conjugation experiment, we strongly recommend performing another round of desalting process. (OriGene recommends Zeba Spin Desalting Columns, 7KMWCO from Thermo Scientific) Purification: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Predicted Protein Size: 80.5 kDa Gene Name: Homo sapiens neurolysin (NLN), mRNA; nuclear gene for mitochondrial product. Database Link: NP_065777 Entrez Gene 75805 MouseEntrez Gene 117041 RatEntrez Gene 696884 MonkeyEntrez Gene 57486 Human Q9BYT8 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 4 NLN Mouse Monoclonal Antibody [Clone ID: OTI1D6] – CF504178 Background: This gene encodes a member of the metallopeptidase M3 protein family that cleaves neurotensin at the Pro10-Tyr11 bond, leading to the formation of neurotensin(1-10) and neurotensin(11-13).
    [Show full text]
  • Transdifferentiation of Human Mesenchymal Stem Cells
    Transdifferentiation of Human Mesenchymal Stem Cells Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Julius-Maximilians-Universität Würzburg vorgelegt von Tatjana Schilling aus San Miguel de Tucuman, Argentinien Würzburg, 2007 Eingereicht am: Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Martin J. Müller Gutachter: PD Dr. Norbert Schütze Gutachter: Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am: Hiermit erkläre ich ehrenwörtlich, dass ich die vorliegende Dissertation selbstständig angefertigt und keine anderen als die von mir angegebenen Hilfsmittel und Quellen verwendet habe. Des Weiteren erkläre ich, dass diese Arbeit weder in gleicher noch in ähnlicher Form in einem Prüfungsverfahren vorgelegen hat und ich noch keinen Promotionsversuch unternommen habe. Gerbrunn, 4. Mai 2007 Tatjana Schilling Table of contents i Table of contents 1 Summary ........................................................................................................................ 1 1.1 Summary.................................................................................................................... 1 1.2 Zusammenfassung..................................................................................................... 2 2 Introduction.................................................................................................................... 4 2.1 Osteoporosis and the fatty degeneration of the bone marrow..................................... 4 2.2 Adipose and bone
    [Show full text]
  • NLN (NM 020726) Human Tagged ORF Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC212447 NLN (NM_020726) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: NLN (NM_020726) Human Tagged ORF Clone Tag: Myc-DDK Symbol: NLN Synonyms: AGTBP; EP24.16; MEP; MOP Vector: pCMV6-Entry (PS100001) E. coli Selection: Kanamycin (25 ug/mL) Cell Selection: Neomycin This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 5 NLN (NM_020726) Human Tagged ORF Clone – RC212447 ORF Nucleotide >RC212447 representing NM_020726 Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGATCGCCCGGTGCCTTTTGGCTGTGCGAAGCCTCCGCAGAGTTGGTGGTTCCAGGATTTTACTCAGAA TGACGTTAGGAAGAGAAGTGATGTCTCCTCTTCAGGCAATGTCTTCCTATACTGTGGCTGGCAGAAATGT TTTAAGATGGGATCTTTCACCAGAGCAAATTAAAACAAGAACTGAGGAGCTCATTGTGCAGACCAAACAG GTGTACGATGCTGTTGGAATGCTCGGTATTGAGGAAGTAACTTACGAGAACTGTCTGCAGGCACTGGCAG ATGTAGAAGTAAAGTATATAGTGGAAAGGACCATGCTAGACTTTCCCCAGCATGTATCCTCTGACAAAGA AGTACGAGCAGCAAGTACAGAAGCAGACAAAAGACTTTCTCGTTTTGATATTGAGATGAGCATGAGAGGA GATATATTTGAGAGAATTGTTCATTTACAGGAAACCTGTGATCTGGGGAAGATAAAACCTGAGGCCAGAC GATACTTGGAAAAGTCAATTAAAATGGGGAAAAGAAATGGGCTCCATCTTCCTGAACAAGTACAGAATGA AATCAAATCAATGAAGAAAAGAATGAGTGAGCTATGTATTGATTTTAACAAAAACCTCAATGAGGATGAT
    [Show full text]
  • NLN Mouse Monoclonal Antibody [Clone ID: OTI2F2] – CF504159
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for CF504159 NLN Mouse Monoclonal Antibody [Clone ID: OTI2F2] Product data: Product Type: Primary Antibodies Clone Name: OTI2F2 Applications: FC, WB Recommended Dilution: WB 1:2000, FLOW 1:100 Reactivity: Human, Mouse, Rat Host: Mouse Isotype: IgG1 Clonality: Monoclonal Immunogen: Full length human recombinant protein of human NLN(NP_065777) produced in HEK293T cell. Formulation: Lyophilized powder (original buffer 1X PBS, pH 7.3, 8% trehalose) Reconstitution Method: For reconstitution, we recommend adding 100uL distilled water to a final antibody concentration of about 1 mg/mL. To use this carrier-free antibody for conjugation experiment, we strongly recommend performing another round of desalting process. (OriGene recommends Zeba Spin Desalting Columns, 7KMWCO from Thermo Scientific) Purification: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Predicted Protein Size: 80.5 kDa Gene Name: Homo sapiens neurolysin (NLN), mRNA; nuclear gene for mitochondrial product. Database Link: NP_065777 Entrez Gene 75805 MouseEntrez Gene 117041 RatEntrez Gene 57486 Human Q9BYT8 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 NLN Mouse Monoclonal Antibody [Clone ID: OTI2F2] – CF504159 Background: This gene encodes a member of the metallopeptidase M3 protein family that cleaves neurotensin at the Pro10-Tyr11 bond, leading to the formation of neurotensin(1-10) and neurotensin(11-13).
    [Show full text]
  • Database Connection and Annotating Models
    Database connection Import model from BioModels.net Database connection Akira Funahashi Keio University, Japan Database connection Database connection Import model from BioModels.net Import model from JWS Online Database connection Database connection Import model from PANTHER Import model from PANTHER Database connection Comparison Import model from PANTHER •BioModels.net •Curated •Can simulate •No CellDesigner Layout •Panther DB •Curated •Can not simulate •CellDesigner Layout SABIO-RK CellDesigner ⇔ SABIO RK •Web-accessible database •Users can import additional information •http://sabio.h-its.org/ to each object (reaction) on-the-fly •Contains information about biochemical •SBML (Systems Biology Markup Language) reactions, related kinetic equations and is used to exchange information parameters CellDesigner E Name, EC number S P Vmax[S] Km +[S] kinetic law, parameters, function / unit definitions Integration Example •Import kinetic law, parameters to the model from SABIO-RK Example Example Example Example Example Annotating a model Akira Funahashi Keio University, Japan V IEWPOINT Peripheral insulin resistance contributes to Jnk1 in obese mice, or inhibition of serine mice increases insulin sensitivity, revealing type 2 diabetes, but ␤-cell failure is the es- kinases by salicylates, reduces Ser phosphor- targets for inhibitor design. However, inhibi- sential feature of all types of diabetes. ␤ cells ylation of IRS proteins and reverses hyper- tion of SHIP2 or pTEN might be risky be- frequently fail to compensate for insulin re- glycemia, hyperinsulinemia, and dyslipide- cause they stabilize PI(3,4,5)P3, which can sistance, apparently because the IRS2-branch mia in obese rodents by sensitizing insulin stimulate cell growth. By contrast, PTP1B of the insulin and IGF signaling cascade is signaling pathways (18).
    [Show full text]
  • An Expression-Independent Catalog of Genes from Human Chromosome 22 James A
    Downloaded from genome.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press RESEARCH An Expression-independent Catalog of Genes from Human Chromosome 22 James A. Trofatter, l'3 Kimberly R. Long, 1'3 Jill R. Murrell, 1 Christy J. Stotler, 1 James F. Gusella, 1'2 and Alan J. Buckler 1'4 Molecular Neurogenetics Unit, Departments of 1Neurology and 2Genetics, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129 To accomplish large-scale identification of genes from a single human chromosome, exon amplification was applied to large pools of clones from a flow-sorted human chromosome 22 cosmid library. Sequence analysis of more than one-third of the 6400 cloned products identified 35% of the known genes previously localized to this chromosome, as well as several unmapped genes and randomly sequenced cDNAs. Among the more interesting sequence similarities are those that represent novel human genes that are related to others with known or putative functions, such as one exon from a gene that may represent the human homolog of Drosophila Polycomb. it is anticipated that sequences from at least half of the genes residing on chromosome 22 are contained within this exon library. This approach is expected to facilitate fine-structure physical and transcription mapping of human chromosomes, and accelerate the process of disease gene identification. A primary goal of the human genome initiative is proaches based on hybridization and biological the construction of fine-structure physical maps selection (Auch and Reth 1990; Duyk et al. 1990; of the chromosomes in anticipation of full DNA Buckler et al.
    [Show full text]
  • MAFB Determines Human Macrophage Anti-Inflammatory
    MAFB Determines Human Macrophage Anti-Inflammatory Polarization: Relevance for the Pathogenic Mechanisms Operating in Multicentric Carpotarsal Osteolysis This information is current as of October 4, 2021. Víctor D. Cuevas, Laura Anta, Rafael Samaniego, Emmanuel Orta-Zavalza, Juan Vladimir de la Rosa, Geneviève Baujat, Ángeles Domínguez-Soto, Paloma Sánchez-Mateos, María M. Escribese, Antonio Castrillo, Valérie Cormier-Daire, Miguel A. Vega and Ángel L. Corbí Downloaded from J Immunol 2017; 198:2070-2081; Prepublished online 16 January 2017; doi: 10.4049/jimmunol.1601667 http://www.jimmunol.org/content/198/5/2070 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2017/01/15/jimmunol.160166 Material 7.DCSupplemental References This article cites 69 articles, 22 of which you can access for free at: http://www.jimmunol.org/content/198/5/2070.full#ref-list-1 by guest on October 4, 2021 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2017 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606.
    [Show full text]
  • Transcriptional Profile of Human Anti-Inflamatory Macrophages Under Homeostatic, Activating and Pathological Conditions
    UNIVERSIDAD COMPLUTENSE DE MADRID FACULTAD DE CIENCIAS QUÍMICAS Departamento de Bioquímica y Biología Molecular I TESIS DOCTORAL Transcriptional profile of human anti-inflamatory macrophages under homeostatic, activating and pathological conditions Perfil transcripcional de macrófagos antiinflamatorios humanos en condiciones de homeostasis, activación y patológicas MEMORIA PARA OPTAR AL GRADO DE DOCTOR PRESENTADA POR Víctor Delgado Cuevas Directores María Marta Escribese Alonso Ángel Luís Corbí López Madrid, 2017 © Víctor Delgado Cuevas, 2016 Universidad Complutense de Madrid Facultad de Ciencias Químicas Dpto. de Bioquímica y Biología Molecular I TRANSCRIPTIONAL PROFILE OF HUMAN ANTI-INFLAMMATORY MACROPHAGES UNDER HOMEOSTATIC, ACTIVATING AND PATHOLOGICAL CONDITIONS Perfil transcripcional de macrófagos antiinflamatorios humanos en condiciones de homeostasis, activación y patológicas. Víctor Delgado Cuevas Tesis Doctoral Madrid 2016 Universidad Complutense de Madrid Facultad de Ciencias Químicas Dpto. de Bioquímica y Biología Molecular I TRANSCRIPTIONAL PROFILE OF HUMAN ANTI-INFLAMMATORY MACROPHAGES UNDER HOMEOSTATIC, ACTIVATING AND PATHOLOGICAL CONDITIONS Perfil transcripcional de macrófagos antiinflamatorios humanos en condiciones de homeostasis, activación y patológicas. Este trabajo ha sido realizado por Víctor Delgado Cuevas para optar al grado de Doctor en el Centro de Investigaciones Biológicas de Madrid (CSIC), bajo la dirección de la Dra. María Marta Escribese Alonso y el Dr. Ángel Luís Corbí López Fdo. Dra. María Marta Escribese
    [Show full text]
  • Table S1. 103 Ferroptosis-Related Genes Retrieved from the Genecards
    Table S1. 103 ferroptosis-related genes retrieved from the GeneCards. Gene Symbol Description Category GPX4 Glutathione Peroxidase 4 Protein Coding AIFM2 Apoptosis Inducing Factor Mitochondria Associated 2 Protein Coding TP53 Tumor Protein P53 Protein Coding ACSL4 Acyl-CoA Synthetase Long Chain Family Member 4 Protein Coding SLC7A11 Solute Carrier Family 7 Member 11 Protein Coding VDAC2 Voltage Dependent Anion Channel 2 Protein Coding VDAC3 Voltage Dependent Anion Channel 3 Protein Coding ATG5 Autophagy Related 5 Protein Coding ATG7 Autophagy Related 7 Protein Coding NCOA4 Nuclear Receptor Coactivator 4 Protein Coding HMOX1 Heme Oxygenase 1 Protein Coding SLC3A2 Solute Carrier Family 3 Member 2 Protein Coding ALOX15 Arachidonate 15-Lipoxygenase Protein Coding BECN1 Beclin 1 Protein Coding PRKAA1 Protein Kinase AMP-Activated Catalytic Subunit Alpha 1 Protein Coding SAT1 Spermidine/Spermine N1-Acetyltransferase 1 Protein Coding NF2 Neurofibromin 2 Protein Coding YAP1 Yes1 Associated Transcriptional Regulator Protein Coding FTH1 Ferritin Heavy Chain 1 Protein Coding TF Transferrin Protein Coding TFRC Transferrin Receptor Protein Coding FTL Ferritin Light Chain Protein Coding CYBB Cytochrome B-245 Beta Chain Protein Coding GSS Glutathione Synthetase Protein Coding CP Ceruloplasmin Protein Coding PRNP Prion Protein Protein Coding SLC11A2 Solute Carrier Family 11 Member 2 Protein Coding SLC40A1 Solute Carrier Family 40 Member 1 Protein Coding STEAP3 STEAP3 Metalloreductase Protein Coding ACSL1 Acyl-CoA Synthetase Long Chain Family Member 1 Protein
    [Show full text]
  • NLN Mouse Monoclonal Antibody [Clone ID: OTI3A12] Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TA503978 NLN Mouse Monoclonal Antibody [Clone ID: OTI3A12] Product data: Product Type: Primary Antibodies Clone Name: OTI3A12 Applications: FC, IHC, WB Recommended Dilution: WB 1:2000, IHC 1:150, FLOW 1:100 Reactivity: Human, Mouse, Rat Host: Mouse Isotype: IgG2a Clonality: Monoclonal Immunogen: Full length human recombinant protein of human NLN(NP_065777) produced in HEK293T cell. Formulation: PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. Concentration: 0.94 mg/ml Purification: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Predicted Protein Size: 80.5 kDa Gene Name: neurolysin Database Link: NP_065777 Entrez Gene 75805 MouseEntrez Gene 117041 RatEntrez Gene 57486 Human Q9BYT8 Background: This gene encodes a member of the metallopeptidase M3 protein family that cleaves neurotensin at the Pro10-Tyr11 bond, leading to the formation of neurotensin(1-10) and neurotensin(11-13). The encoded protein is likely involved in the termination of the neurotensinergic signal in the central nervous system and in the gastrointestinal tract. Synonyms: AGTBP; EP24.16; MEP; MOP This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 5 NLN Mouse Monoclonal Antibody [Clone ID: OTI3A12] – TA503978 Protein Families: Druggable Genome, Protease Protein Pathways: Renin-angiotensin system Product images: HEK293T cells were transfected with the pCMV6- ENTRY control (Left lane) or pCMV6-ENTRY NLN ([RC212447], Right lane) cDNA for 48 hrs and lysed.
    [Show full text]